Andrea Wartenberg‐Demand

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Tobias Welte, R. Phillip Dellinger, Henning Ebelt et al. · Intensive Care Medicine · 2018 · 136 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

Sundar Jagannath, Leonard T. Heffner, Sikander Ailawadhi et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 83 citations

Medicine, Oncology, Pharmacotherapy +9

Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips

Alexandra Gramowski, Konstantin Jügelt, Simone Stüwe et al. · European Journal of Neuroscience · 2006 · 67 citations

Medicine, Neuroscience, Pharmacology +17

BT062, an Antibody-Drug Conjugate Directed Against CD138, Given Weekly for 3 Weeks in Each 4 Week Cycle: Safety and Further Evidence of Clinical Activity

Leonard T. Heffner, Sundar Jagannath, Todd M. Zimmerman et al. · Blood · 2012 · 60 citations

Pharmacy, Oncology, Pharmacology +12

Indatuximab Ravtansine (BT062) in Combination with Low-Dose Dexamethasone and Lenalidomide or Pomalidomide: Clinical Activity in Patients with Relapsed / Refractory Multiple Myeloma

Kevin R. Kelly, David S. Siegel, Asher Chanan‐Khan et al. · Blood · 2016 · 54 citations

Medicine, Oncology, Pharmacotherapy +13